[Lipoprotein (a)]

K Makino1, A Noma

  • 1Department of Laboratory Medicine, Gifu University School of Medicine.

Insights

Lipoprotein (a) is a key risk factor for cardiovascular disease due to its structure and similarity to plasminogen. Further research is needed to understand its role and develop drugs to lower its levels.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Molecular Biology

Context:

  • Lipoprotein (a) [Lp (a)] is an LDL particle linked to apolipoprotein (a) [apo (a)].
  • Lp (a) is an independent risk factor for atherosclerotic cardiovascular disease.
  • Apo (a) shares significant homology with plasminogen, prompting interest in Lp (a)'s atherogenic and thrombotic mechanisms.

Purpose:

  • To review recent advances in understanding the atherogenicity and thrombogenicity mechanisms of Lp (a).
  • To highlight the need for further research into the physiological role of Lp (a).
  • To emphasize the urgent requirement for therapeutic strategies to reduce serum Lp (a) levels.

Summary:

  • Recent advances in the atherogenic and thrombotic mechanisms of Lp (a) are reviewed.
  • The physiological role of Lp (a) remains largely unknown and requires further investigation.
  • Developing drugs to lower serum Lp (a) concentrations is a critical unmet need.

Impact:

  • Provides a review of current knowledge on Lp (a) mechanisms.
  • Identifies knowledge gaps regarding Lp (a)'s physiological function.
  • Underscores the clinical need for Lp (a)-lowering therapies to mitigate cardiovascular risk.

Related Concept Videos

What are Lipids?01:38

What are Lipids?

Overview
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...